# Radiolabeled TSPO Targeted Molecular Probe in Glioma

> **NCT07106008** · — · NOT_YET_RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 8 (estimated)

## Conditions studied

- Glioma (Any Grade) in the Brain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07106008
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07106008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07106008, "Radiolabeled TSPO Targeted Molecular Probe in Glioma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT07106008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*